Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Roivant Sciences (ROIV) Shares Outstanding (Weighted Average): 2020-2025

Historic Shares Outstanding (Weighted Average) for Roivant Sciences (ROIV) over the last 5 years, with Sep 2025 value amounting to $682.9 million.

  • Roivant Sciences' Shares Outstanding (Weighted Average) fell 7.66% to $682.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $682.9 million, marking a year-over-year decrease of 7.66%. This contributed to the annual value of $713.5 million for FY2025, which is 11.45% down from last year.
  • According to the latest figures from Q3 2025, Roivant Sciences' Shares Outstanding (Weighted Average) is $682.9 million, which was up 0.45% from $679.8 million recorded in Q2 2025.
  • Over the past 5 years, Roivant Sciences' Shares Outstanding (Weighted Average) peaked at $805.8 million during Q1 2024, and registered a low of $51.3 million during Q1 2021.
  • Over the past 3 years, Roivant Sciences' median Shares Outstanding (Weighted Average) value was $739.5 million (recorded in 2024), while the average stood at $744.5 million.
  • As far as peak fluctuations go, Roivant Sciences' Shares Outstanding (Weighted Average) spiked by 1,248.02% in 2022, and later declined by 11.45% in 2025.
  • Over the past 5 years, Roivant Sciences' Shares Outstanding (Weighted Average) (Quarterly) stood at $684.8 million in 2021, then grew by 5.93% to $725.4 million in 2022, then grew by 10.82% to $803.9 million in 2023, then decreased by 9.45% to $727.9 million in 2024, then decreased by 7.66% to $682.9 million in 2025.
  • Its last three reported values are $682.9 million in Q3 2025, $679.8 million for Q2 2025, and $713.5 million during Q1 2025.